BANK OF AMERICA CORP /DE/ - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 85 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$76,201
-49.1%
34,480
-41.5%
0.00%
Q1 2023$149,652
+2.3%
58,918
-24.7%
0.00%
Q4 2022$146,228
-8.0%
78,197
+26.1%
0.00%
Q3 2022$159,000
+23.3%
62,006
-7.2%
0.00%
Q2 2022$129,000
-69.7%
66,781
-53.4%
0.00%
Q1 2022$426,000
-18.4%
143,369
+23.5%
0.00%
Q4 2021$522,000
-30.5%
116,120
-25.0%
0.00%
Q3 2021$751,000
-24.2%
154,724
+6.5%
0.00%
Q2 2021$991,000
-18.8%
145,275
-16.0%
0.00%
Q1 2021$1,221,000
+36.1%
172,947
+20.7%
0.00%
Q4 2020$897,000
-24.0%
143,327
-34.3%
0.00%
Q3 2020$1,180,000
+22.8%
218,221
+18.6%
0.00%
Q2 2020$961,000
+1216.4%
184,035
+693.7%
0.00%
Q1 2020$73,000
-33.6%
23,187
-15.2%
0.00%
Q4 2019$110,000
-18.5%
27,345
-12.1%
0.00%
Q3 2019$135,000
+28.6%
31,114
+18.9%
0.00%
Q2 2019$105,000
-33.1%
26,165
-10.8%
0.00%
Q1 2019$157,000
+30.8%
29,318
+24.7%
0.00%
Q4 2018$120,000
-25.0%
23,504
+43.1%
0.00%
Q3 2018$160,000
-17.5%
16,430
-14.0%
0.00%
Q2 2018$194,000
-26.2%
19,097
-5.6%
0.00%
Q1 2018$263,000
+92.0%
20,228
+163.8%
0.00%
Q4 2017$137,000
-59.3%
7,668
-42.9%
0.00%
Q3 2017$337,000
+37.0%
13,427
+32.1%
0.00%
Q2 2017$246,000
-68.9%
10,168
-75.3%
0.00%
Q1 2017$792,000
+495.5%
41,093
+373.1%
0.00%
Q4 2016$133,000
+250.0%
8,686
+198.3%
0.00%
Q3 2016$38,000
-67.2%
2,912
-65.0%
0.00%
Q2 2016$116,000
+286.7%
8,322
+316.1%
0.00%
Q1 2016$30,000
-31.8%
2,000
-12.9%
0.00%
Q4 2015$44,000
-29.0%
2,295
-30.2%
0.00%
Q3 2015$62,000
+55.0%
3,287
+111.0%
0.00%
Q2 2015$40,000
-77.3%
1,558
-72.3%
0.00%
Q1 2015$176,000
+245.1%
5,620
+322.6%
0.00%
Q4 2014$51,0001,3300.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders